On a Plasminogen Activator from Human Plasma

Summary

A plasminogen activating substance was purified from the dialysates of the eluates of glass adsorbed kallikrein from fresh human plasma, by chromatography on QAE-Sephadex A-50 and gel filtration in Sephadex G-25. The preparation was concentrated by lyophilization. Its electrophoretic mobility was found to be similar to that of prealbumin. Its molecular weight appeared to be 15000–18000 daltons. The analysis of aminoacids of this activator showed that it contains a high proportion of acid amino acids. The purified activator showed esterase activity, fibrinolytic activity and kininogenase activity on heated human plasma. These activities were respectively equivalent to 150 μM BAE^e/mg protein, 19 × 10³ units of streptokinase/μg protein and 250 μg bradykinin/mg protein.

• References

• 1 Andrews P. 1970. Methods in biochemical analysis. 18 53 Ed David Glick Interscience Publishers; New York, London:
• 2 Astrup T, Mullertz G. 1952; Fibrin plate method for estimating fibrinolytic activity. Archives Biochemistry 40: 346
• 3 Brown ME. 1960; Esterase Activity. Journal Laboratory Clinical Medicine 55: 516
• 4 Cawley LP, Eberhard L. 1962; Simplified gel electrophoresis. I. Rapid technique applicable to the clinical laboratory. American Journal Clinical Pathology 38: 539
• 5 Colman RW. 1969; Activation of Plasminogen by human plasma kallikrein. Biochemical Biophysical Research Communications 35: 273
• 6 Davis BJ. 1964; Disc electrophoresis. II. Method and application to human serum proteins. Annals of the New York Academy of Science 121: 404
• 7 Diaz A, Corral JF, Henriques OlgaB. 1978; Estudio at liberación “espontánea” de Quininas en fracciones parcialmente purificadas de quininógeno I y II del plasma humano. Actualizaciones en Hematologfa 3: 79
• 8 Henriques OG, Allan L. 1972; Glass activates kallikrein from human plasma. Biochemical Pharmacology 21: 3163
• 9 Kaplan AP, Austen KF. 1972; The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. Journal Experimental Medicine 136: 1378
• 10 Laake K, Venneröd AM. 1974; Factor XII induced fibrinolysis: Studies on the separation of prekallikrein, plasminogen proactivator and factor XI in human plasma. Thrombosis Research 4: 285
• 11 Lowry CH, Rosebrough NJ, Farr AL, Randal RJ. 1951; Protein measurement with the folin phenol reagent. Journal Biological Chemistry 193: 265
• 12 Ogston D, Ogston MC, Ratnoff OD. 1969; Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: The participation of Hageman factor and additional cofactors. Journal Clinical Investigation 48: 1786
• 13 Ogston D, Bennett B, Mackie M. 1976; Properties of a partially purified preparation of a circulating plasminogen activator. Thrombosis Research 8: 275
• 14 Ratnoff OD, Davie EW. 1962; The purification of activated Hageman Factor (Activated factor XII). Biochemistry 1: 967
• 15 Spackman DH, Stein WH, Moore S. 1958; Automatic recording apparatus for use in the chromatography of amino acids. Annals Chemistry 30: 1190
• 16 Spragg J, Kaplan Allen P, Austen KFRANK. 1973; The use of iseolectric focusing to study components of the human plasma kinin-forming system. Annals of the New York Academy of Sciences 209: 372
• 17 Vennerod AM, Laake K. 1974; Isolation and characterization of prealbumen activator of prekallikrein from acetone activated human plasma. Thrombosis Research 4: 103
• 18 Vennerod AM, Laake K. 1976; Prekallikrein and plasminogen activator absence of plasminogen proactivator in Fletcher factor deficient palsma. Thrombosis Research 8: 519
• 19 Weber K, Osborn M. 1969; The reliability of molecular weight determination by Dodesyl sulphate polyacrylamide gel electrophoresis. The Journal of Biological Chemistry 244: 4406